Archive page of posts in this category or categories:

The following posts are in no particular order. They are purposely randomized.

RSI News

QuarterWatch analyzes MedWatch Reports

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing…

Read More
RSI News

IAI climate change report

The International Aluminium Institute (IAI) recently commissioned Climate Risk Institute (CRI) and Risk Sciences International (RSI) to produce a series of informational tools evaluating and explaining the future effects of climate change on the aluminium sector’s sustainability. A principle focus of the project was to highlight one of the most consequential effects of climate change,…

Read More
RSI News

Training Seminar in Systematic Review

RSI recently conducted an in-house training session in systematic review for its staff. The session featured a keynote presentation by Dr. Katya Tsaioun from Johns Hopkins University, who provided an overview of best practices in systematic review.  The training included two systemic applications of systematic review, and current software in systematic review was studied. The…

Read More
RSI News

Country Foods Forum

Leading up to February 11 and 12, 2020, Risk Sciences International had the privilege of assisting Health Canada in its organization of the Country Foods Forum. The event attracted a number of experts in country foods risk assessment from across Canada. Participants and speakers represented a broad cross section of stakeholders ranging from scientists to…

Read More
RSI News

RSI receives National Defence funding

RSI is pleased to be the recipient of funding through the DND IDEaS COVID-19 Challenge. Under the supervision of Emma Hartnett, RSI will be developing a risk-based tool to support public health emergency response planning for COVID-19, and other infectious disease and mass casualty emergencies in the future. The safety and well-being of Canadians are…

Read More
RSI News

Climate change modelling for the Bow River watershed

Developing a suite of watershed-scale climate models.

Read More
RSI News

Decision making framework developed for Canadian Blood Services (CBS) now online

RSI was contracted by CBS to assist the Alliance of Blood Operators in the development of a blood-safety oriented risk-based decision-making framework. Why use this framework?  Streamline the process of assessing blood safety risk and make informed blood safety decisions. To access the Framework on the Alliance of Blood Operators site users will need to…

Read More
RSI News

RSI contributes to newly published book on Blood Safety.

Written by experts in the field, Blood Safety: A Guide to Monitoring and Responding to Potential New Threats offers a concise yet comprehensive overview on critical issues in monitoring and responding to new microbial threats to blood safety.  The Book was edited by Hua Shan and Roger Dodd and recently published by Springer. RSI’s Anne Wiles, is lead author for…

Read More
RSI News

RSI hosts Mitacs intern

Risk Sciences International will host Abdallah Alami as an intern in statistics with support from the Mitacs Accelerate program. This unique university-industry program supports interns at Canadian companies while completing graduate their training at Canadian universities.    Mr. Alami will be completing his MSc in statistics at Carleton University under the supervision of Professor Patrick Farrell and…

Read More
RSI News

QuarterWatch analyzes MedWatch Reports

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing…

Read More